Learn more about whether Ligand Pharmaceuticals Incorporated or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In a live virtual event, Attaya Suvannasankha, MD, discussed the MajesTEC-1 trial of teclistamab and approaches to mitigation ...

At the American Society of Haematology (ASH) congress, Sanofi reported that Sarclisa (isatuximab) added to the standard KRd regimen of Amgen’s Kyprolis (carfilzomib), lenalidomide, and ...

Sanofi has also completed a second study of Sarclisa added to the standard KRd regimen of Amgen’s Kyprolis (carfilzomib), lenalidomide, and dexamethasone in previously untreated, transplant ...

At close: 11 April at 16:00:00 GMT-4 ...